Drug management of oxidation-reduction state of the body in respiratory tract diseases (part 6)
The review of the literature presents modern data on antioxidant and anti-inflammatory activity of polyphenols, as well as their representatives curcumin and resveratrol in diseases of the respiratory system.
A.E. Abaturov +2 more
doaj +1 more source
Relevance. Acute respiratory diseases (ARD) refer to mass infectious diseases, cause significant economic damage by provoking the development of diseases of the circulatory system, and the seasonal incidence of ARI is a predictor of mortality from ...
M. A. Papicheva, I. I. Yakushina
doaj +1 more source
Understanding Viral Transmission Behavior via Protein Intrinsic Disorder Prediction: Coronaviruses [PDF]
Besides being a common threat to farm animals and poultry, coronavirus (CoV) was responsible for the human severe acute respiratory syndrome (SARS) epidemic in 2002-4. However, many aspects of CoV behavior, including modes of its transmission, are yet to
Dunker, A. Keith +2 more
core +3 more sources
Drug management of oxidation-reduction state of the body in respiratory tract diseases (part 5)
The review of the literature presents modern data on antioxidant activity and immunomodulatory action of vitamin A in diseases of the respiratory system.
A.E. Abaturov +2 more
doaj +1 more source
New opportunities for inhaled therapy for inflammatory diseases of the respiratory system [PDF]
The paper considers current approaches to mucoregulatory therapy for various inflammatory diseases of the respiratory system. It gives the advantages and disadvantages of common drugs used in their treatment.
G L Ignatova, V N Antonov
doaj +1 more source
National mortality burden due to communicable, non-communicable, and other diseases in Ethiopia, 1990–2015: findings from the Global Burden of Disease Study 2015 [PDF]
Background: Ethiopia lacks a complete vital registration system that would assist in measuring disease burden and risk factors. We used the Global Burden of Diseases, Injuries, and Risk factors 2015 (GBD 2015) estimates to describe the mortality burden ...
A Misganaw +45 more
core +2 more sources
Drug management of oxidation-reduction state of the body in respiratory tract diseases (part 1)
The review of the literature presents the classification of antioxidant drugs. Modern data are presented on the inhibitors of NOX activity such as natural, synthetic (non-selective and selective), renin-angiotensin-aldosterone system blocking drugs and ...
A.E. Abaturov +2 more
doaj +1 more source
Currently, the assessment of immune status in patients with COVID-19 is limited to determining the count of polymorphonuclear leukocytes and the phagocytic function of neutrophils, which is insufficient to understand the regulatory role of innate ...
Irina Anatolyevna Andrievskaya +4 more
doaj +1 more source
The carotid body as a therapeutic target for the treatment of sympathetically mediated diseases [PDF]
[no ...
Abdala, Ana P +13 more
core +2 more sources
By dawn or dusk—how circadian timing rewrites bacterial infection outcomes
The circadian clock shapes immune function, yet its influence on infection outcomes is only beginning to be understood. This review highlights how circadian timing alters host responses to the bacterial pathogens Salmonella enterica, Listeria monocytogenes, and Streptococcus pneumoniae revealing that the effectiveness of immune defense depends not only
Devons Mo +2 more
wiley +1 more source

